复方樟柳碱联合葛根素注射液治疗眼底缺血性疾病的疗效  

Clinical observation on compound anisodine combined with puerarin injection treating ocular fundus ischemic disease

作　　者：蔡峻[1] 刘子彬[1] 许丹丹[1] 刘海俊[1] 

机构地区：[1]解放军421医院眼科,中国广东省广州市510318

出　　处：《国际眼科杂志》2012年第3期556-557,共2页International Eye Science

摘　　要：目的:探讨复方樟柳碱联合葛根素注射液治疗眼底缺血性疾病疗效。方法:采用回顾性的随机分组方法,将2006-03/2011-03治疗的眼底缺血性疾病104例患者中分成3组(联合治疗组36例、樟柳碱组34例、葛根素组34例)。结果:治疗后联合组总有效率(92%,33/36)显著高于葛根素组(62%,21/34)和樟柳碱组(65%,22/34),联合组与对照组治疗后总有效率比较差异有统计学意义(P<0.05),两对照组间总有效率比较差异无统计学意义(P>0.05)。结论:复方樟柳碱联合葛根素注射液对眼底缺血性疾病有显著疗效。AIM：To evaluate the effects of compound anisodinchemic disease. METHODS：The patients of 104 cases were randomly divided into three groups （ ce combined with puerarin injection in treatment for ocular fundus isombination group 36 cases; compound anisodine injection group 34 cases; puerarin injection group 34 cases） according to retrospective study. RESULTS：After treatment,total effective rate of the combination group, compound anisodine group and puerarin injection group were 92% （33/36）,65% （22/34） and 62% （21/34）; There was a great difference between the combination group and the control groups（P0.05）, and no significant difference was found between two control groups（P0.05）. CONCLUSION：Compound anisodine injection combined with puerarin injection has special effects on treating ocular fundus ischemic disease.

关 键 词：复方樟柳碱 葛根素 眼底缺血性病变 

分 类 号：R773.4[医药卫生—眼科]